Reversible arrhythmias observed in patients treated with recombinant alpha2 interferon

  • Silvana Martino
  • Voravit Ratanatharathorn
  • Chatchada Karanes
  • Bohumil A. Samal
  • Young Ho Sohn
  • Seth A. Rudnick
Original Papers Clinical Oncology or Epidemiology

Summary

We have treated 25 patients, 7 with breast cancer and 18 with non-Hodgkin's lymphoma, with recombinant alpha2 interferon. In 5 patients we observed cardiac arrhythmias that were unexpected and required treatment. No deaths have occured that we can attribute to interferon, though 1 patient had to be resuscitated. Age, prior cardiac disease, prior treatment with doxorubicin, and interferon dose appear to be predisposing factors for this toxicity.

Key words

Cardiac toxicity Recombinant alpha2 interferon 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Blalock JE, Stanton JD (1980) Common pathways of interferon and hormonal action. Nature 283:406–408Google Scholar
  2. 2.
    Budd GT, Bukowski RM, Miketo L, Yen-Lieberman B, Proffitt MR (1984) Phase-I trial of ultrapure human leukocyte interferon in human malignancy. Cancer Chemother Pharmacol 12:39–42Google Scholar
  3. 3.
    Calvet MC, Gresser I (1979) Interferon enhances the excitability of cultured neurons. Nature 278:558–560Google Scholar
  4. 4.
    Dickson D (1982) Death halts interferon trials in France. Science 218:772Google Scholar
  5. 5.
    Foon KA, Sherwin SA, Abrams PG, Longo DL, Fer MF, Stevenson HC, Ochs JJ, Bottino GC, Schoenberger CS, Zeffren J, Jaffe ES, Oldham RK (1984) Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon. New Engl J Med 311:1148–1152Google Scholar
  6. 6.
    Kirkwood JM, Ernstoff MS (1984) Interferons in the treatment of human cancer. J Clin Oncol 2(4):336–349Google Scholar
  7. 7.
    Lampidis TJ, Brouty-Boye D (1981) Interferon inhibits cardiac cell function in vitro. Proc Soc Exp Biol Med 166:181–185Google Scholar
  8. 8.
    Sarna G, Figlin R, Callaghan M (1983) (Human Leukocyte)-interferon as treatment for non-small cell carcinoma of the lung: a phase II trial. J Biol Response Mod 2(4):343–347Google Scholar
  9. 9.
    Usui N (1983) Clinical trial of human lymphoblastoid interferon on advanced malignancy. Gan To Kagaku Ryoho 10(11):2324–2329Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • Silvana Martino
    • 1
  • Voravit Ratanatharathorn
    • 1
  • Chatchada Karanes
    • 1
  • Bohumil A. Samal
    • 1
  • Young Ho Sohn
    • 1
  • Seth A. Rudnick
    • 1
  1. 1.Department of MedicineWayne State University School of Medicine, and Harper-Grace HospitalDetroitUSA

Personalised recommendations